Department of Surgery

Simmons Research Conferences

"Acute Limb Ischemia Epidemiology and Outcomes" Presented by Dr. Marissa Jarosinski, MD

I will present preliminary data of epidemiology, disparities, and costs of acute limb ischemia derived from the National Inpatient Sample (NIS). I will also be presenting finalized data regarding short-term outcomes of
percutaneous vs. open thrombectomy from the NIS. Finally, I will present
preliminary data using UPMC data comparing the same procedures.

Mentors: Drs. Natalie Sridharan, MD, Katherine Reitz, MD, and Edith Tzeng, MD

Perioperative Circadian Optimization: Development of a Randomized Controlled Trial Evaluating Blue Light Therapy in Rectal Cancer

Project 1: "Deprivation Mediates Income Inequality's Association with Colorectal Cancer" 

Mentor: Dr. Robert Tessler, MD, MPH

 Project 2: "The Role of Holistic Review in Diversifying Graduate Medical Education: A Systematic Review and Meta-analysis"

Mentor: Dr. Sara Myers, MD, PhD

"EMS quality metrics and social determinants of health" and "Matrix-Bound Nanovesicles"

Presenter: Sebastian Boland, MD

Title: EMS quality metrics and social determinants of health

Description: My projects involve the prehospital care of trauma patients and the role that social determinants of health play in the quality of prehospital care. I am interested in using existing metrics and establishing novel metrics to better define "high-quality care" in the prehospital setting and inform best practices. 

Mentor:  Dr. Joshua Brown

Presenter: Dr. Joud Mulla, MD

"Acute Limb Ischemia: A Two Pronged Approach"

Title: Acute Limb Ischemia: A Two Pronged Approach
Acute Limb Ischemia remains a morbid and deadly diagnosis, with a 1-year amputation free survival rate of 50-60%. Postoperative medication regimen consists of long term anticoagulation in patients with embolic disease, but is poorly defined in patients with acute on chronic disease. In the era of personalized medicine, novel strategies are emerging to characterize bleeding and clotting risks, such as TEG. In our proposed study, we hope to prospectively use TEG to characterize risk of thrombotic outcomes.